Skip to content

Investigating the Effect of Implementing a Family-Friendly Program (Based on the MBCT Approach with Parent-Child Interaction) on the Reduction of Parental Anxiety Sensitivity and Separation Anxiety Disorder in Children and Adolescents

N. Rahmani, S. Teymuri, M. Bayazi, A. Rajaei

The American journal of family therapy June 1, 2021 DOI: 10.1080/01926187.2021.1917015 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Population Parents and their children and adolescents
Intervention Family-friendly program (FFP)
Measures Screen for Child Anxiety Related Disorder-71 (SCARED-71), anxiety sensitivity questionnaire for parents
Topics Anxiety Meditation
Key findings The family-friendly program significantly reduced parental anxiety sensitivity and separation anxiety in children and adolescents compared with a control group, with a significant between-group difference at post-test (p < 0.0001).

Abstract

Abstract This study aimed to investigate the effect of the family-friendly program (FFP) on reducing parental anxiety sensitivity (PAS) and also Separation Anxiety disorders (SAD) in children and adolescents. Subjects in both groups responded to the Screen for Child Anxiety Related Disorder-71 (SCARED-71) (to diagnose separation) and the anxiety sensitivity questionnaire for parents, before intervention (pretest) and immediately after the intervention (posttest). ANCOVA test via SPSS 23 showed that there was a significant difference between the test and control groups in the post-test (p < 0.0001). Teaching FFP affects reducing PAS and also SAD in children and adolescents.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics